IP Library Granted Patent US 8,026,349
Granted Patent B2
US 8,026,349 · App. 11/660,589 · Granted Sep 27, 2011

Polynucleotide synthesis labeling chemistry

Assignee: Dharmacon, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,349
App. No.
11/660,589
Granted
Sep 27, 2011
Kind
B2
Abstract

Methods and compositions for making nucleoside phosphoramidites and nucleic acids, including mono-, di-, and polynucleotides, comprising a linker covalently attached to a levulinyl moiety are provided. A levulinyl-protected linking moiety affords an orthogonal approach to modifying a polynucleotide during or after solid phase synthesis with a molecule of interest, for example, a conjugate or a dye.

Claims (20)

1. A composition, comprising:

wherein L comprises a linker; Z 1 is an oxygen or a sulfur; Z 2 is an oxygen or a sulfur; and S comprises a solid support useful for the synthesis of nucleic acids, wherein the linker is attached to S through a covalent linkage, and the linker comprises a functional group through which the linker can attach to a polynucleotide, and the linker further comprises at least one of an alkane, an alkene, a polyether, a polyalcohol, a polyester, a polyamine, a polyalkylamine, a polyphosphodiseter, a polyethylene glycol, a polypropylene, a propylene glycol, a mixture of ethylene and propylene glycols, or a combination thereof.

2. The composition according to claim 1 , wherein the linker moiety comprises an alkene, a polyether, a polyalcohol, a polyester, a polyamine, a polyalkylamine, a polyphosphodiester, or a combination thereof.

3. An oligonucleotide attached to a solid synthesis support, wherein the solid synthesis support comprises a composition of claim 1 .

4. An oligonucleotide attached to a solid synthesis support, wherein the solid synthesis support comprises a composition of claim 1 , and the oligonucleotide comprises one or more compositions comprising:

wherein B comprises a nitrogenous base that is modified or unmodified; L comprises a linker moiety; Z 1 is an oxygen or a sulfur; Z 2 is an oxygen or a sulfur; P 1 comprises a blocking group; and P 2 comprises a phosphorous moiety.

5. An oligonucleotide attached to a solid synthesis support, wherein the solid synthesis support comprises a composition of claim 1 , and the oligonucleotide comprises one or more compositions comprising:

wherein L comprises a non-nucleosidic linker moiety; Z 1 is an oxygen or a sulfur; Z 2 is an oxygen or a sulfur; and P comprises a phosphorous moiety.

6. An oligonucleotide attached to a solid synthesis support, wherein the solid synthesis support comprises a composition of claim 1 , and the oligonucleotide comprises one or more compositions comprising:

wherein B comprises a nitrogenous base that is modified or unmodified; L comprises a linker moiety; Z 1 is an oxygen or a sulfur; Z 2 is an oxygen or a sulfur; P 1 comprises a blocking group; and P 2 comprises a phosphorous moiety, and

a composition comprising:

wherein L comprises a non-nucleosidic linker moiety; Z 1 is an oxygen or a sulfur; Z 2 is an oxygen or a sulfur; and P comprises a phosphorous moiety.

7. A method of synthesizing an oligonucleotide comprising adding one more nucleotides to the composition of claim 1 .

8. The composition of claim 1 wherein the linker is attached to the solid support through a succinate, glutarate or oxalate linkage.

9. The composition of claim 1 , wherein the solid support comprises controlled pore glass, polystyrene or polymethacrylate.

10. The composition of claim 1 , wherein S and L are attached through a covalent amide bond.

11. The composition of claim 1 , wherein the covalent linkage is through a converted hydroxyl group.

12. The composition of claim 1 , wherein Z 1 is sulfur.

13. The composition of claim 1 , wherein Z 2 is sulfur.

14. The composition of claim 12 , wherein Z 2 is sulfur.

Assignments (4)
CHANGE OF NAME Recorded Oct 2, 2017
From: GE HEALTHCARE DHARMACON, INC.
To: DHARMACON, INC.
Reel/Frame 044105/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
To: GE HEALTHCARE DHARMACON, INC.
Reel/Frame 032863/0603 →
CHANGE OF NAME Recorded Apr 15, 2014
From: DHARMACON, INC.
To: THERMO FISHER SCIENTIFIC BIOSCIENCES INC.
Reel/Frame 032689/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2007
From: HARTSEL, STEPHANIE A.; KAISER, ROBERT J.; DELANEY, MICHAEL O.
To: DHARMACON, INC.
Reel/Frame 018980/0520 →
Continuity (2)
Provisional Application 60603472 · Aug 20, 2004
Related Publication 20080009612A1 · Jan 10, 2008